OraSure Technologies Up 16.9% Since SmarTrend Uptrend Call (OSUR)
Comtex SmarTrend(R) - Thu Jul 31, 10:01AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on June 10th, 2014 at $7.06. In approximately 2 months, OraSure Technologies has returned 16.94% as of today's recent price of $8.25.
Meridian Bioscience Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 12:58PM CDT
For fiscal 2014, Meridian Bioscience, Inc. (VIVO) expects earnings per share between 85 and 90 cents while revenues are expected in the range of $190 to $195 million.
St. Jude Medical Gets CE Mark for FlexAbility Catheter - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 5:10PM CDT
The CE Mark approval of the FlexAbility catheter boosted St. Jude Medical's (STJ) ablation technology portfolio in Europe.
Shares of OSUR Up 20.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 24, 9:25AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on June 10th, 2014 at $7.06. In approximately 1 month, OraSure Technologies has returned 20.20% as of today's recent price of $8.48.
Boston Scientific Rises on Launch of POLARIS Imaging System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 3:55PM CDT
Share price of medical device major Boston Scientific Corporation (BSX) rose 2.4% yesterday, following the full commercial launch of its new POLARIS system
Mead Johnson (MJN) Misses on Q2 Earnings, Beats Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 1:45PM CDT
Mead Johnson (MJN) has upgraded its full year 2014 guidance for both earnings and revenue
OraSure Technologies Earnings Conference Call Invitation
GlobeNewswire - Tue Jul 22, 5:00AM CDT
2014 Second Quarter Earnings Conference Call
athenahealth Falls Despite Q2 Beat and Higher Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 8:20AM CDT
On a reported basis, athenahealth (ATHN) posted a narrower loss of $2.2 million, or 6 cents per share, in the quarter compared with $12.4 million, or 34 cents per share, in the second quarter of 2014
Market Has Not Yet Noticed Potential in OraSure Technologies (OSUR); Have You? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 7:32AM CDT
OraSure Technologies has been witnessing a positive momentum in the earnings estimate front and possess a favorable Zacks Rank
Boston Scientific's 25 mm Lotus Valve Wins CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 4:10PM CDT
Management at Boston Scientific (BSX) is enthusiastic about the commercial launch of the Lotus Valve system only seven months after its initial launch revealing their commitment to improving therapy modes and patient outcomes.
Wheeling Hospital Renews Allscripts Healthcare's Sunrise EHR - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 12:30PM CDT
By leveraging Allscripts Healthcare Solutions, Inc.'s (MDRX) Sunrise EHR and open platform solutions, Wheeling Hospital intends to meet regulatory requirements, manage population health and improve patient outcomes across all its facilities.
St. Jude Medical Beats on Q2 Earnings, Upgrades Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 11:35AM CDT
For full year 2014, St. Jude Medical (STJ) upgraded its adjusted earnings per share guidance to $3.96 to $4.01 from the prior range of $3.95-$4.00
Alere's Diagnostic Test Shows Accurate HIV Detection in Infants - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 15, 4:30PM CDT
The ability of Alere's (ALR) test to provide results in less than an hour has been highly regarded by physicians because it can help them initiate anti-retroviral treatment in HIV-positive infants much earlier.
St. Jude Medical to Acquire Chronic Pain Solutions Maker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 15, 1:50PM CDT
The acquisition will boost St. Jude Medical's (STJ) chronic pain portfolio.
Baxter International Hits a Record High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 14, 4:15PM CDT
Since the beginning of this year, shares of Baxter International Inc. (BAX) have been on the rise, posting an impressive year-to-date return of 12.3%.
Quality Systems Subsidiary Offers EHR Solutions to HMC/CAH - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 14, 2:00PM CDT
Revenues of Quality Systems (QSII) continue to be largely boosted by the strength of the NextGen subsidiary.
Smith & Nephew Ink Robotic Surgical Deal with Blue Belt Tech - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 11, 6:20PM CDT
Smith & Nephew's (SNN) JOURNEY UNI partial implant provides an advanced alternative to total knee replacement for patients who have a portion of their knees damaged due to osteoarthritis.
NeuroMetrix's OTC Pain Management Device Gets FDA Nod, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 1:50PM CDT
Following the news, NeuroMetrix's (NURO) share price surged 19% to eventually close at $2.25 yesterday.
Baxter International Acquires Orphan Drug Producer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 12:20PM CDT
The acquisition will help Baxter International (BAX) address a highly unmet clinical need of patients suffering from blood-related disorders